ストックスクリーナーアプリを入手
0.665
1.40%
0.014
Matinas Biopharma Holdings Inc (MTNB) 最新ニュース
MSN Money - MSN
Net current asset value per share of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
Operating cash flow per share of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
Matinas BioPharma Holdings, Inc. (MTNB) - Minichart
Sell Signal: Will Matinas BioPharma Holdings Inc benefit from government policy2026 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn
Aug Setups: Can Matinas BioPharma Holdings Inc generate free cash flow2026 Fed Impact & Verified Chart Pattern Signals - baoquankhu1.vn
Analyst Upgrade: Can Matinas BioPharma Holdings Inc ride the EV waveJobs Report & Real-Time Volume Analysis - baoquankhu1.vn
Aug Wrap: What are the risks of holding Matinas BioPharma Holdings Inc2026 Earnings Surprises & High Accuracy Trade Alerts - baoquankhu1.vn
SHPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Matinas BioPharma Receives NYSE American Non-Compliance Notice Due to Stockholders’ Equity and Ongoing Losses 1 - Minichart
SHPH PE Ratio & Valuation, Is SHPH Overvalued - Intellectia AI
Matinas BioPharma Faces NYSE Compliance Issues - Intellectia AI
Heritage Signs & Displays Completes JD Lewis Center Transformative Branding Project in Raleigh, NC - Weekly Voice
Matinas BioPharma Holdings, Inc. Notifies NYSE American of Non-Compliance with Continued Listing Standards - Quiver Quantitative
Matinas BioPharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Matinas BioPharma (NYSE American: MTNB) faces NYSE non-compliance and cure deadline - Stock Titan
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - ChartMill
MAT2203 stakes rise as Matinas BioPharma (NYSE: MTNB) slashes staff, seeks partner - Stock Titan
Gains Recap: What are the future prospects of Matinas BioPharma Holdings IncEarnings Performance Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Germany Stocks: Research Stocks from Germany Stock Market - GuruFocus
TOTDY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
DBSM.SI Should I Buy - Intellectia AI
Volume Recap: Will Matinas BioPharma Holdings Inc outperform tech stocks2026 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn
BHAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MTNB PE Ratio & Valuation, Is MTNB Overvalued - Intellectia AI
Aug Update: Is Matinas BioPharma Holdings Inc a stock for growth or value investors2026 Pullback Review & Safe Entry Momentum Stock Tips - baoquankhu1.vn
ES=F PE Ratio & Valuation, Is ES=F Overvalued - Intellectia AI
Performance Recap: What are the future prospects of Matinas BioPharma Holdings Inc2026 Momentum & Breakout Confirmation Trade Signals - baoquankhu1.vn
Volume Recap: Whats the beta of Matinas BioPharma Holdings Inc stockTrade Exit Report & Low Risk High Win Rate Picks - baoquankhu1.vn
MTNB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Dow Update: Can Matinas BioPharma Holdings Inc keep up with sector leaders2026 Technicals & Fast Entry and Exit Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
002044.SZ Forecast — Price Prediction for 2026. Should I Buy 002044.SZ? - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CLF Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving PremarketC3.ai - Benzinga
Gainers Report: How does ATHPRC correlate with NasdaqSwing Trade & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Can Matinas BioPharma Holdings Inc. ride the EV waveJuly 2025 Review & Risk Managed Trade Strategies - Mfd.ru
Is Matinas BioPharma Holdings Inc. a stock for growth or value investorsJuly 2025 Recap & Safe Capital Growth Tips - mfd.ru
Why Matinas BioPharma Holdings Inc. (6LJ0) stock is favored by hedge fundsWeekly Stock Report & High Accuracy Investment Signals - mfd.ru
Can Matinas Biopharma Holdings Inc. stock survive global slowdownWeekly Investment Report & Consistent Growth Stock Picks - mfd.ru
Entry Recap: Is Matinas BioPharma Holdings Inc exposed to currency risksJuly 2025 Catalysts & Weekly Breakout Watchlists - baoquankhu1.vn
What are the future prospects of Matinas BioPharma Holdings Inc.Trade Risk Summary & Smart Allocation Stock Tips - mfd.ru
What is Matinas BioPharma Holdings Inc. s P E ratio telling us2025 Biggest Moves & Safe Entry Zone Identification - mfd.ru
Can Matinas BioPharma Holdings Inc. stock outperform in 2025 bull market2025 Key Lessons & Weekly High Return Forecasts - mfd.ru
Merger Talk: Can Matinas BioPharma Holdings Inc ride the EV waveTrade Performance Summary & High Conviction Trade Alerts - baoquankhu1.vn
Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO By Investing.com - Investing.com Nigeria
Matinas BioPharma CEO Named Interim Chief Financial Officer - The Globe and Mail
Matinas BioPharma appoints CEO Jerome Jabbour as interim CFO - Investing.com
0.78%
3.01%
大文字化:
|
ボリューム (24 時間):